Used primarily in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors. It shows particular relevance in the development of targeted cancer therapies, where it acts as a scaffold for compounds that modulate signaling pathways involved in tumor growth and proliferation. Its structure allows for selective interaction with ATP-binding sites in protein kinases, making it valuable in the design of drugs for treating cancers such as leukemia and non-small cell lung carcinoma. Additionally, derivatives of this compound are explored for their potential in treating inflammatory diseases and neurological disorders due to their ability to cross the blood-brain barrier and exhibit central nervous system activity.